|
Summary:
2527 Antineovascularizing Agents Country:
Norway Estimated Cost:
NOK 670000000 Notice Type:
Tender Notice Deadline:
26 Nov 2024 Posting Date:
18 Oct 2024 |
|
Summary:
2527 Antineovascularizing Agents Country:
Norway Estimated Cost:
NOK 670000000 Notice Type:
Tender Notice Deadline:
26 Nov 2024 Posting Date:
18 Oct 2024 |
|
Summary:
2527 Antineovaskularizing Agents Country:
Norway Estimated Cost:
EUR 670000000 Notice Type:
Tender Notice Deadline:
26 Nov 2024 Posting Date:
17 Oct 2024 |
|
Summary:
Monitoring Of The Medicines Adalimumab And Infliximab, Tests For Concentration In Serum To St. Olav Hospital H Country:
Norway
Notice Type:
Tender Notice Deadline:
08 Nov 2024 Posting Date:
16 Oct 2024 |
|
Summary:
Monitoring Of The Drugs Adalimumab And Infliximab, Tests For Concentration In Serum To St. Olav Hospital H Country:
Norway Estimated Cost:
NOK 3000000 Notice Type:
Tender Notice Deadline:
08 Nov 2024 Posting Date:
16 Oct 2024 |
|
Summary:
2506B Tnf Bio Country:
Norway Estimated Cost:
NOK 1650000000 Notice Type:
Tender Notice Deadline:
08 Nov 2024 Posting Date:
04 Oct 2024 |
|
Summary:
Monitoring Of The Drugs Adalimumab And Infliximab, Tests For Concentration In Serum To St. Olav Hospital H Country:
Norway Estimated Cost:
NOK 3000000 Notice Type:
Tender Notice Deadline:
08 Nov 2024 Posting Date:
04 Oct 2024 |
|
Summary:
2599K Deferasiroks Country:
Norway Estimated Cost:
NOK 6000000 Notice Type:
Tender Notice Deadline:
12 Nov 2024 Posting Date:
04 Oct 2024 |
|
Summary:
2599M Sapropterin Country:
Norway Estimated Cost:
NOK 60000000 Notice Type:
Tender Notice Deadline:
12 Nov 2024 Posting Date:
04 Oct 2024 |
|
Summary:
Monitoring Of The Drugs Adalimumab And Infliximab, Tests For Concentration In Serum To St. Olav Hospital H Country:
Norway Estimated Cost:
NOK 3000000 Notice Type:
Tender Notice Deadline:
08 Nov 2024 Posting Date:
04 Oct 2024 |
Most trusted source for Tendering Opportunities and Business Intelligence since 2002